HIGHLIGHTS
- who: Walter Bodmer from the Weatherall Institute University of have published the paper: Two contrasting papers stimulate a commentary on the origins of tumour immunology, current cancer immunotherapies, and the future potential for cancer immunotherapy, in the Journal: (JOURNAL) of 13/Oct/2022
- future: While there are still many hurdles in the way monoclonal antibody mediated killing of cancer cells expressing ectopic proteins is I believe so far the only sure way to get future cancerspecific-based treatments that can be coupled with check point blocking or other combinations.
SUMMARY
The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.